相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。Comprehensive Expression Profiling of Tumor Cell Lines Identifies Molecular Signatures of Melanoma Progression
Byungwoo Ryu et al.
PLOS ONE (2007)
Inhibition of the mitogen-activated protein kinase pathway results in the down-regulation of P-glycoprotein
Kazuhiro Katayama et al.
MOLECULAR CANCER THERAPEUTICS (2007)
Targeting the Raf-MEK-ERK mitogen-activated protein kinase cascade for the treatment of cancer
P. J. Roberts et al.
ONCOGENE (2007)
MAP kinase signalling pathways in cancer
A. S. Dhillon et al.
ONCOGENE (2007)
Selective inhibition of ADAM metalloproteases as a novel approach for modulating ErbB pathways in cancer
Jordan S. Fridman et al.
CLINICAL CANCER RESEARCH (2007)
Oncogenic activation of the RAS/RAF signaling pathway impairs the response of metastatic colorectal cancers to anti-epidermal growth factor receptor antibody therapies
Silvia Benvenuti et al.
CANCER RESEARCH (2007)
Melanoma biology and new targeted therapy
Vanessa Gray-Schopfer et al.
NATURE (2007)
Lack of extracellular signal-regulated kinase mitogen-activated protein kinase signaling shows a new type of melanoma
Janiel M. Shields et al.
CANCER RESEARCH (2007)
Suppression of BRAF/MEK/MAP kinase pathway restores expression of iodide-metabolizing genes in thyroid cells expressing the V600E BRAF mutant
Dingxie Liu et al.
CLINICAL CANCER RESEARCH (2007)
ADAM10 inhibition of human CD30 shedding increases specificity of targeted immunotherapy in vitro
Dennis A. Eichenauer et al.
CANCER RESEARCH (2007)
p38 kinase regulates epidermal growth factor receptor downregulation and cellular migration
Mark R. Frey et al.
EMBO JOURNAL (2006)
Mutation analysis of 24 known cancer genes in the NCI-60 cell line set
Ogechi N. Ikediobi et al.
MOLECULAR CANCER THERAPEUTICS (2006)
Role of the mitogen-activated protein kinase signaling pathway in the regulation of human melanocytic antigen expression
Michihiro Kono et al.
MOLECULAR CANCER RESEARCH (2006)
Targeting ADAM-mediated ligand cleavage to inhibit HER3 and EGFR pathways in non-small cell lung cancer
Bin-Bing S. Zhou et al.
CANCER CELL (2006)
Multiple signaling pathways must be targeted to overcome drug resistance in cell lines derived from melanoma metastases
KSM Smalley et al.
MOLECULAR CANCER THERAPEUTICS (2006)
Glycoprotein nonmetastatic melanoma protein B, a potential molecular therapeutic target in patients with glioblastoma multiforme
CT Kuan et al.
CLINICAL CANCER RESEARCH (2006)
CR011, a fully human monoclonal anti body-auristatin E conjugate, for the treatment of melanoma
KF Tse et al.
CLINICAL CANCER RESEARCH (2006)
BRAF status and mitogen-activated protein/extracellular signal-regulated kinase kinase 1/2 activity indicate sensitivity of melanoma cells to anthrax lethal toxin
RJ Abi-Habib et al.
MOLECULAR CANCER THERAPEUTICS (2005)
Mutation analysis of the Ras pathway genes NRAS, HRAS, KRAS and BRAF in glioblastomas
CB Knobbe et al.
ACTA NEUROPATHOLOGICA (2004)
Exposure of melanoma cells to dacarbazine results in enhanced tumor growth and metastasis in vivo
DC Lev et al.
JOURNAL OF CLINICAL ONCOLOGY (2004)
The ADAMs family of metalloproteases: multidomain proteins with multiple functions
DF Seals et al.
GENES & DEVELOPMENT (2003)
Apoptosis and melanogenesis in human melanoma cells induced by anthrax lethal factor inactivation of mitogen-activated protein kinase kinase
HM Koo et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2002)
Mutations in genes encoding melanosomal proteins cause pigmentary glaucoma in DBA/2J mice
MG Anderson et al.
NATURE GENETICS (2002)
Improving the efficacy of antibody-based cancer therapies
P Carter
NATURE REVIEWS CANCER (2001)
Dissection of ras-dependent signaling pathways controlling aggressive tumor growth of human fibrosarcoma cells: Evidence for a potential novel pathway
S Gupta et al.
MOLECULAR AND CELLULAR BIOLOGY (2000)